lasofoxifene has been researched along with deoxypyridinoline in 3 studies
| Studies (lasofoxifene) | Trials (lasofoxifene) | Recent Studies (post-2010) (lasofoxifene) | Studies (deoxypyridinoline) | Trials (deoxypyridinoline) | Recent Studies (post-2010) (deoxypyridinoline) |
|---|---|---|---|---|---|
| 88 | 14 | 24 | 1,364 | 261 | 143 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foley, GL; Ke, HZ; Shen, V; Simmons, HA; Thompson, DD | 1 |
| Armamento-Villareal, R; Brodt, MD; Caruso, PL; Civelli, M; Civitelli, R; Galbiati, E; Halstead, LR; Mueller, C; Napoli, N; Nawaz, A; Sheikh, S; Silva, MJ | 1 |
| Calcagni, A; Dogolo, L; Fountaine, RJ; Gardner, MJ; Nishizawa, Y; Wei, G | 1 |
1 trial(s) available for lasofoxifene and deoxypyridinoline
| Article | Year |
|---|---|
Clinical pharmacology of lasofoxifene in Japanese and white postmenopausal women.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Amino Acids; Asian People; Cholesterol, HDL; Cholesterol, LDL; Collagen Type I; Double-Blind Method; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Middle Aged; Peptides; Postmenopause; Pyrrolidines; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; White People | 2006 |
2 other study(ies) available for lasofoxifene and deoxypyridinoline
| Article | Year |
|---|---|
Long-term treatment of lasofoxifene preserves bone mass and bone strength and does not adversely affect the uterus in ovariectomized rats.
Topics: Amino Acids; Animals; Biomechanical Phenomena; Bone and Bones; Compressive Strength; Creatinine; Drug Administration Schedule; Female; Genitalia, Female; Lumbar Vertebrae; Organ Size; Osteocalcin; Ovariectomy; Pyrrolidines; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Tibia; Tomography, X-Ray Computed; Uterus | 2004 |
A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
Topics: Absorptiometry, Photon; Amino Acids; Animals; Benzopyrans; Biomechanical Phenomena; Blood; Body Composition; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Cholesterol; Compressive Strength; Estrogen Receptor Modulators; Ethinyl Estradiol; Female; Femur; Femur Neck; Lumbar Vertebrae; Organ Size; Osteoclasts; Osteogenesis; Ovariectomy; Piperidines; Pyrrolidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes; Tibia; Tomography, X-Ray Computed; Triglycerides; Uterus; Weight-Bearing | 2005 |